Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
05/2014
05/21/2014CN103800287A 大蒜素自微乳的制备方法 Preparation of allicin self microemulsion
05/21/2014CN103800283A 一种芬太尼凝胶制剂及其制备方法 A gel formulation of fentanyl and its preparation method
05/21/2014CN103800282A 灯盏花素鼻用微乳凝胶制剂及其制备方法 Breviscapine nasal gel microemulsion formulation and preparation method
05/21/2014CN103800280A 氟伐他汀钠药物组合物 Fluvastatin sodium pharmaceutical composition
05/21/2014CN103800279A 阿托伐他汀钙组合物 Atorvastatin calcium composition
05/21/2014CN103800278A 透明质酸联合聚桂醇在制备治疗静脉畸形泡沫硬化药物中的应用 Hyaluronic acid in the preparation of the joint lauromacrogol treatment of venous malformations foam sclerosis drug application
05/21/2014CN103800277A 一种来氟米特醇质体组合物及其制备方法 One kind of leflunomide ethosomes composition and its preparation method
05/21/2014CN103156855B 一种酚咖缓释胶囊及其制备方法 A phenol-release capsules and coffee preparation methods
05/21/2014CN103145847B 一种抗cd20抗体-海兔毒素偶联物及其制备方法和应用 Aplysia toxin conjugates and its preparation method and application - an anti-cd20 antibody
05/21/2014CN103142545B 一种依托泊苷肠溶胶囊 One kind of etoposide enteric-coated capsules
05/21/2014CN103142533B 一种依托泊苷肠溶片 One kind of etoposide enteric-coated tablets
05/21/2014CN103127030B 一种藻酸双酯钠肠溶胶囊及其制备方法 A sodium alginate ester enteric-coated capsules and its preparation method
05/21/2014CN103127013B 藻酸双酯钠脂质体片剂 Sodium alginate ester liposomes tablet
05/21/2014CN103083280B 维生素c软胶囊 Vitamin c soft capsules
05/21/2014CN103044523B 地塞米松-rgd多肽缀合物，其制备方法及应用 Dexamethasone -rgd polypeptide conjugates, their preparation and application
05/21/2014CN102961345B 一种雷帕霉素/磁性羧甲基壳聚糖纳米载药微球的制备方法 Method for preparing rapamycin / Magnetic carboxymethyl chitosan nanoparticles loaded microspheres of
05/21/2014CN102895669B 一种顺铂配合物及其制备方法 Cisplatin complexes and its preparation method
05/21/2014CN102836142B 一种空心胶囊及其制备方法 One kind of hollow capsules and its preparation method
05/21/2014CN102670521B 一种埃索美拉唑镁肠溶微丸及其制备方法 One kind of esomeprazole magnesium enteric-coated pellets and its preparation method
05/21/2014CN102657627B 稳定的硫酸氢氯吡格雷片剂及其制备方法 Stability of clopidogrel hydrogen sulfate and its preparation method tablet
05/21/2014CN102552206B 一种具有抗炎镇痛作用的药物组合物 The pharmaceutical compositions having anti-inflammatory and analgesic effects
05/21/2014CN102525981B 一种盐酸普萘洛尔片及其制备方法 One kind of propranolol hydrochloride tablets and its preparation method
05/21/2014CN102356094B 纯化瓜尔胶的方法 Purification methods guar gum
05/21/2014CN102327230B 一种包裹紫杉烷类药物的蛋白纳米颗粒及其制备方法 One kind of wrapped taxanes protein nanoparticles and its preparation method
05/21/2014CN102319205B 布洛芬注射液及其制备方法 Ibuprofen Injection and its preparation method
05/21/2014CN101880405B 一种生物可降解球形多孔淀粉泡沫的制备方法与应用 A biodegradable starch prepared spherical porous foam and Applications
05/21/2014CN101721364B 一种喜树碱类化合物磷脂复合物水分散体及其制备方法 A compound of the camptothecin class of phospholipid complex aqueous dispersion and its preparation method
05/21/2014CN101721354B 由双挤压法制备的眼植入物 Ocular implants prepared by double extrusion legal
05/21/2014CN101618020B 二氢吡啶类钙离子拮抗剂的固体自乳化口服给药系统及其制备方法 Dihydropyridine calcium antagonists oral solid self-emulsifying drug delivery system and its preparation method
05/21/2014CN101343624B 一种重组人生长激素基因的杆状病毒及其制备方法与应用 Baculovirus and its preparation method and application of a recombinant human growth hormone gene
05/20/2014US8729246 Agent delivery system capable of selectively releasing an agent
05/20/2014US8729127 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders
05/20/2014US8729126 Use of pufas for treating skin inflammation
05/20/2014US8729094 Liquid pharmaceutical formulations of palonosetron
05/20/2014US8729037 Method and medicament for inhibiting the expression of a given gene
05/20/2014US8729022 Stabilised solid compositions of factor VII polypeptides
05/20/2014US8729010 Compositions and methods for enhancing drug delivery across and into ocular tissues
05/20/2014US8728747 Alteration of cell membrane for new functions
05/20/2014US8728524 Biomaterials consisting of sulphated hyaluronic acid and gellan to be used in the prevention of spinal adhesions
05/20/2014US8728511 Method of treatment comprising administering controlled release melatonin
05/20/2014US8728504 Process for solubilizing hydrophobic active ingredients in aqueous medium
05/20/2014US8728483 Multivalent fibronectin based scaffold domain proteins
05/20/2014US8728480 Methods for the treatment of tumors expressing TAT123 or naturally occurring variants thereof
05/20/2014US8728449 Water-soluble film article having salt layer, and method of making the same
05/20/2014US8728448 Use of agglomerated hydroxyethylcellulose in pharmaceutical, personal care and household care applications
05/20/2014CA2770509C Silicone modified fatty acids, method of preparation and usage thereof
05/20/2014CA2634989C Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
05/20/2014CA2624588C Anticoagulant antithrombotic dual inhibitors comprising a biotin label
05/20/2014CA2619601C Long acting injectable parasiticidal formulations
05/20/2014CA2585664C Biodegradable linkers for molecular therapies
05/20/2014CA2585116C Sustained release formulation comprising bisphosphonate
05/20/2014CA2471192C Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments
05/15/2014WO2014074952A1 Methods and compositions for localized delivery of agents to hiv-infected cells and tissues
05/15/2014WO2014074808A1 Pharmaceutical core-shell composite powder and processes for making the same
05/15/2014WO2014074605A1 Preserved topical formulations with improved antimicrobial activity
05/15/2014WO2014074584A1 On-demand drug release using magneto-electric nanoparticles
05/15/2014WO2014074289A1 Delivery of biologically-active agents using volatile, hydrophobic solvents
05/15/2014WO2014074007A1 Dermatological composition with indicator properties
05/15/2014WO2014073698A1 Nystose crystal-containing powder
05/15/2014WO2014073675A1 Thick liquid diet
05/15/2014WO2014073447A1 Polymeric compound having camptothecin compound and anti-cancer effect enhancer bound thereto, and use of same
05/15/2014WO2014072999A1 Nanocomplex containing cationic peptide for biomolecule delivery
05/15/2014WO2014072997A1 Nanocomplex containing amphipathic peptide useful for efficient transfection of biomolecules
05/15/2014WO2014072897A1 Anti-notch3 antibodies and antibody-drug conjugates
05/15/2014WO2014072888A1 Anti-il-13 receptor alpha 2 antibodies and antibody-drug conjugates
05/15/2014WO2014072647A1 Co-micronisation product comprising a selective progesterone-receptor modulator
05/15/2014WO2014072646A1 Co-micronisation product comprising ulipristal acetate
05/15/2014WO2014072482A1 Recognition tags for tgase-mediated conjugation
05/15/2014WO2014072411A1 C4s proteoglycan specific transporter molecules
05/15/2014WO2014072330A1 Glucose responsive hydrogel comprising pba-grafted hyaluronic acid (ha)
05/15/2014WO2014072306A1 Her3 antigen binding proteins binding to the beta-hairpin of her3
05/15/2014WO2014071757A1 Sevelamer carbonate medicinal tablet composition and preparation method thereof
05/15/2014WO2014071743A1 Composition containing antifungal drug and lactate buffer
05/15/2014WO2014071531A1 Aprotinin-derived polypeptide-antibody conjugates
05/15/2014WO2014071499A1 Pharmaceutical compositions comprising hydromorphone and naloxone
05/15/2014WO2014071449A1 Neuroactive steroids and their use to facilitate neuroprotection
05/15/2014US20140135487 Immunostimulatory g, u-containing oligoribonucleotides
05/15/2014US20140135486 Multi-arm polyethylene glycol derivatives, conjugates and gels of pharmaceuticals and the same
05/15/2014US20140135397 Halogenated phenols for diagnostics, antioxidant protection and drug delivery
05/15/2014US20140135388 Self-Emulsifying Active Ingredient Formulation and the Use of This Formulation
05/15/2014US20140135381 Small molecule conjugates for intracellular delivery of biologically active compounds
05/15/2014US20140135380 Small molecule conjugates for intracellular delivery of nucleic acids
05/15/2014US20140135376 Nanogels
05/15/2014US20140135357 Dose regime for camptothecin derivatives
05/15/2014US20140135355 Abuse-Resistant Controlled-Release Opioid Dosage Form
05/15/2014US20140135349 Aqueous Compositions
05/15/2014US20140135340 High Drug Load Tablet
05/15/2014US20140135286 Compositions and methods for inhibiting adhesion formation
05/15/2014US20140135267 Interfering rna delivery system and uses thereof
05/15/2014US20140135263 Rapid Acting Injectable Insulin Compositions
05/15/2014US20140135230 Lipoparticles Comprising Proteins, Methods Of Making, And Using The Same
05/15/2014US20140134260 Cationic lipids and methods for the delivery of therapeutic agents
05/15/2014US20140134257 Methods of treating melanoma
05/15/2014US20140134256 Drug Microparticles
05/15/2014US20140134244 Antifungal compositions with improved bioavailability
05/15/2014US20140134240 pH INDUCED SILK GELS AND USES THEREOF
05/15/2014US20140134237 Type i interferon mimetics as therapeutics for cancer, viral infections, and multiple sclerosis
05/15/2014US20140134225 Drug/Drug Delivery Systems For The Prevention And Treatment Of Vascular Disease
05/15/2014US20140134204 Methods of improving vaccine immunogenicity
05/15/2014US20140134201 Recombinant vaccines and use thereof
1 ... 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 ... 1712